Trump’s Tariff Stick Won’t Bring Generic Drug Manufacturing Home

Original Article by Damian Garde & Jessica Nix | Bloomberg | 2 June 2025

Analyze the implications of Trump's Tariff Stick for the US generics industry. Tariffs might worsen the supply of critical medicines.

Analyze the implications of Trump’s Tariff Stick for the US generics industry. Tariffs might worsen the supply of critical medicines.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

Older adults with HIV will nearly double by 2040. South Africa faces one of the sharpest rises, straining health systems.

Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.

Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.